Encompass Health (EHC) Projected to Post Quarterly Earnings on Thursday

Encompass Health (NYSE:EHC) will likely be announcing its earnings results after the market closes on Thursday, February 6th. Analysts expect the company to announce earnings of $1.05 per share and revenue of $1.38 billion for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Encompass Health Stock Performance

Shares of EHC stock opened at $101.28 on Wednesday. The business’s 50-day moving average price is $96.44 and its 200-day moving average price is $95.03. Encompass Health has a 12 month low of $70.83 and a 12 month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $10.20 billion, a price-to-earnings ratio of 24.46, a PEG ratio of 1.18 and a beta of 0.90.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on EHC shares. Royal Bank of Canada boosted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Truist Financial restated a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp lifted their target price on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Barclays raised their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.